Enanta Pharmaceuticals | ENTA - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 364.22B 20.46B 2026-05
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.7B 920M 2026-05
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 8.56B 905M 2026-05
Heron Therapeutics USD 238M 7M 2025-12
Immunic USD 64M 23M 2025-12
Incyte USD 21.73B 3B 2026-05
Insmed USD 15.56B 19.73B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
Ligand Pharmaceuticals USD 3.72B 257M 2026-05
Merck USD 297.1B 35.84B 2026-03
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
Novartis USD 232.75B 75B 2026-05
Novavax USD 1.09B 316M 2025-12
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.16B 123M 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05